NF-κB has been identified as a critical mediator of EMT in cancer progression [46–50] and IGF1R pathway has been reported to be involved in EGFR TKI resistance and induction of EMT in lung cancer [34–41, 45]. This evidence concerns the gene NFKB1 and lung carcinoma.